Bay Area Biotech Investor

Corcept Therapeutics: Fourth Time's A Charm For Mifepristone In PMD?

Corcept Therapeutics (NASDAQ:CORT) is a $368M (as of 4/14/2014) pharmaceutical company located in Menlo Park, CA, with 44 employees. Doctors Joseph Belanoff and Alan Schatzberg co-founded Corcept in 1998. Dr. Belanoff previously held multiple positions in the Department of Psychiatry and Behavioral Sciences at Stanford University and is now the CEO of Corcept. While at Stanford Dr. Belanoff published extensively on glucocorticoid signaling with Dr. Schatzberg. Dr. Schatzberg is a professor in the Stanford University School of Medicine Psychiatry and Behavioral Sciences Department and is an expert on glucocorticoid signaling. In the field of psychiatry he had held important administrative appointments, including President of the American Psychiatric Association, won numerous awards, and has published extensively.

Corcept is...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details